Elsevier

Neurobiology of Aging

Volume 108, December 2021, Pages 58-71
Neurobiology of Aging

Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing

https://doi.org/10.1016/j.neurobiolaging.2021.08.004Get rights and content

Highlights

  • Rewarded executive function was assessed in APP/PS1 mice using touchscreens

  • APP/PS1 mice showed a subtle extinction deficit at middle-age

  • Old APP/PS1 mice showed a profound behavioural flexibility deficit

  • Genotype did not affect retinal health as measured by OCT or ERG, but age did

  • This is the first study to show deficits in rewarded extinction or reversal tasks in the APP/PS1 mice

Abstract

Executive function deficits in Alzheimer's disease (AD) occur early in disease progression and may be predictive of cognitive decline. However, no preclinical studies have identified deficits in rewarded executive function in the commonly used APPSwe/PS1∆E9 (APP/PS1) mouse model. To address this, we assessed 12-26 month old APP/PS1 mice on rewarded reversal and/or extinction tasks. 16-month-old, but not 13- or 26-month-old, APP/PS1 mice showed an attenuated rate of extinction. Reversal deficits were seen in 22-month-old, but not 13-month-old APP/PS1 animals. We then confirmed that impairments in reversal were unrelated to previously reported visual impairments in both AD mouse models and humans. Age, but not genotype, had a significant effect on markers of retinal health, indicating the deficits seen in APP/PS1 mice were directly related to cognition. This is the first characterisation of rewarded executive function in APP/PS1 mice, and has great potential to facilitate translation from preclinical models to the clinic.

Introduction

Alzheimer's disease (AD) is one of the biggest health challenges worldwide, with approximately 50 million people currently diagnosed and rates of disease expected to rise in the next 30 years (Alzheimer's Disease International, 2015). Alzheimer's disease is characterised by amyloid plaque build-up, tau hyperphosphorylation, neurodegeneration and cognitive decline (Jack et al., 2013). Due to this increasing burden of disease, AD has been the subject of intense research for many years. In this time, numerous animal models of AD have been generated, with many potential treatments rescuing cognitive symptoms in a wide variety of models. However, all these treatments have failed to halt progression of the disease in clinical trials. Most preclinical animal studies focus on the assessment of hippocampal deficits as an outcome of treatment efficacy. In the clinic however, other early cognitive changes are seen in AD patients including those in executive function. A greater focus on executive function in preclinical animal models is warranted in order to improve the predictive power of these models to determine how effective treatments will be in the clinic.

Patients with mild cognitive impairment (MCI) and early AD patients show executive function deficits on a wide variety of tasks including Tower of London, Stroop Colour-Word Test, Ravens Coloured Progressive Matrices, Ruff Figural Fluency Test, Colour Trails Test Part B, category fluency, backwards digit span, and the Modified Card Sorting Task (Andriuta et al., 2018; Baudic et al., 2006; Huang et al., 2017; Ramanan et al., 2017). In these tasks, patients show attenuated task acquisition and performance, indicatative of prefrontal cortex (PFC) dysfunction (Levy-Gigi et al., 2011). More importantly, executive dysfunction, especially on the Trailmaking Part B test, is predictive of cognitive decline (Mez et al., 2013) and MCI to AD conversion (Albert et al., 2001; Ewers et al., 2012; Gomar et al., 2011; Huang et al., 2017; Johnson et al., 2009). As executive function deficits occur early and, importantly, have the potential to predict cognitive decline and MCI to AD conversion, these symptoms are of great clinical interest but, to date, have not been the focus of testing treatment efficacy in preclinical animal models.

Amyloid-driven mouse models of AD have been shown to have multiple executive function deficits early in their progression. Some models have shown deficits in reversal learning, which assesses a facet of executive function called behavioural flexibility (Chudasama, 2011). Briefly, the animal must first learn one association or rule (i.e. the location of platform in a pool or a stimulus-reward pairing), which is then reversed (i.e. the platform is moved to a different location or a different stimulus is now rewarded). Many AD models have shown reversal impairments in spatial maze-based tasks like Morris water maze (Baruch et al., 2015; Hooijmans et al., 2009; Jankowsky et al., 2005; Marchese et al., 2014; Musilli et al., 2013; Papadopoulos et al., 2013; Stover and Brown, 2012), T water maze (Dong et al., 2005; Filali et al., 2012, 2011; Filali and Lalonde, 2009), cheeseboard (Cheng et al., 2013) and Barnes maze (Stover et al., 2015) as well as olfactory (Girard et al., 2014, Guérin et al., 2009), digging (Shirey et al., 2009; Zhuo et al., 2008) and place preference (Masuda et al., 2016) reversal tasks. AD models have also shown deficits in instrumental extinction, another test of executive function, where the animal must learn to stop responding to a conditioned stimulus (i.e. a stimuli that previously indicated a reward or punishment). Extinction tasks are similar to reversal tasks in that an animal must learn to adjust a stimulus/outcome association, but without having to learn a new rule. AD models show enhanced extinction in rewarded tasks (Romberg et al., 2013) and a mix of attenuated and enhanced extinction in aversive tasks like fear conditioning (Bonardi et al., 2011; Cheng et al., 2019) and conditioned taste aversion (Hanna et al., 2009; Janus et al., 2004; Pardon et al., 2009; Ramírez-Lugo et al., 2009; Rattray et al., 2010). However, the vast majority of tasks applied to AD mouse models either rely on aversive environments or are ethologically relevant to mice; thus they are not analogous to tasks performed clinically, where the patient is responding to stimuli on paper or a screen in a calm environment. As such, we need a paradigm that can assess executive function in non-aversive, human relevant conditions.

Touchscreen testing is a relatively new paradigm to behaviourally test AD mouse models with great translational potential (Shepherd et al., 2016). To date, 3 AD mouse models, the TgCRND8, APPPS1-21 and APPSwDI/Nos2-/- mice, have undergone characterisation of executive function using reversal and extinction paradigms in touchscreens. Contrary to predictions from previously used aversive tasks, TgCRND8 mice show both accelerated reversal and extinction in touchscreens compared to WT mice. This is not due to an accelerated ‘forgetting’ of the first stimulus/reward association, as TgCRND8 mice show intact retention memory for the initial stimulus (Romberg et al., 2013). Conversely, APPSwDI/Nos2-/- mice showed an attenuation of reversal in the touchscreen testing paradigm (Piiponniemi et al., 2017). The APPPS1-21 model showed reduced accuracy in reversal compared to their WT counterparts at 6 and 9 months (Van den Broeck et al., 2019). However, the APPPS1-21 animals performed significantly less trials throughout reversal, thus it is not possible to ascertain if this is a learning or motivational deficit. These conflicting and unclear results highlight the need for more studies focusing on executive function in AD mouse models.

One of the most commonly characterised AD mouse models, the APP/PS1 mouse has not yet been characterised on touchscreen-based executive function tasks. Given previous reports showing slower acquisition of reversal Morris water maze (MWM) at 8 months of age (Hooijmans et al., 2009; Jankowsky et al., 2005; Stover and Brown, 2012) and left-right discrimination learning at 6-9 months old (Filali et al., 2011, 2009) in APP/PS1 mice, we aimed to assess whether reversal learning was impaired in this mouse model using the pairwise discrimination and reversal task. Conflicting findings exist for extinction learning in APP/PS1 mice, with reports of both attenuated (Bonardi et al., 2011) and enhanced extinction to aversive extinction tasks (Cheng et al., 2019; Ramírez-Lugo et al., 2009). When assessed in positively rewarded extinction tasks at 4-8 months of age, APP/PS1 mice did not demonstrate any deficits (Bonardi et al., 2011; Cheng et al., 2013). To resolve this conflict, we set out to test if APP/PS1 mice would show deficits in reward-based executive function tasks using the rodent touchscreen paradigm. We chose to assess 12-month-old and 24-month-old animals on reversal and extinction learning, and 12, 16 and 26-month-old mice in extinction. We chose 12 months of age as this is the best-characterised age in APP/PS1 mice and we wanted this study to be comparable to as many previous studies as possible, and a 24-month-old age group would confirm if a deficit would ever develop in reversal learning. We added the 16-month-old group into extinction as 26-month-old animals struggled to perform the task. We hypothesised that APP/PS1 mice would develop executive function deficits in both appetitive reversal and extinction tasks.

Section snippets

Animals

APP/PS1 mice (APPswe/PS1∆E9 on a C57BL/6J;C3H hybrid background, Jax strain #4462) were obtained from Jackson Laboratory and bred onsite in the SPF facility at the Florey Institute of Neuroscience and Mental Health (Parkville, VIC, Australia). Male APP/PS1 and wildtype littermates (WT) mice from 12-26 months of age were used in experimental procedures. In the results sections, groups of animals are referred to by the rounded average age of the group. Female mice were not tested due to

Pairwise discrimination is unaffected in 12- and 21-month-old APP/PS1 mice

For PD, animals were trained to choose one diagonal contrast-grating image over another for a strawberry milk reward. At 12 months of age, APP/PS1 animals took the same number of trials to reach the criterion where they were deemed to have learned the task (Fig. 1A, χ2 (1) = 0.05, p = 0.82). Regression models were then used to analyse this data at the trial level, to assess the likelihood (or odds) that the APP/PS1 mice would choose the correct, rewarded image compared to the incorrect,

Discussion

In this study, we have shown a progressive executive function deficit in APP/PS1 mice, with intact performance in the reversal learning task at 13 months of age and a deficit appearing by 22 months of age. This impairment was independent of changes in pairwise discrimination and any genotype-mediated structural and functional changes to the retina. Extinction learning was assessed at 13, 16 and 26 months of age, and was found to first be impaired by 16 months. This is the first demonstration of

Disclosure statement

The authors report no conflicts of interest.

A.S is supported by an Australian Government Research Training Program Scholarship and Yulgilbar top-up scholarship. A.M.Z.J is supported by an Australian Government Research Training Program Scholarship A.J.H. is a National Health and Medical Research Council (NHMRC) Principal Research Fellow and has been supported by an Australian Research Council (ARC) FT3 Future Fellowship (FT100100835). E.L.B. is supported by a NHMRC-ARC Dementia Research

Acknowledgements

We would like to thank past and present laboratory members for useful discussions and technical assistance. We thank Britany Cuic, Maddison Ible, Daniel Drieberg, Shannon Currin Craig Thompson and Brett Purcell for their assistance in mouse husbandry and management of equipment. Thank you to Nippy's Ltd, for the donation of Ice Strawberry milk to our study. A.S is supported by an Australian Government Research Training Program Scholarship and Yulgilbar top-up scholarship. A.M.Z.J is supported

CRediT authorship contribution statement

Amy Shepherd: Conceptualization, Methodology, Formal analysis, Investigation, Writing – original draft, Visualization, Writing – review & editing. Jeremiah K.H. Lim: Methodology, Formal analysis, Investigation, Writing – original draft, Visualization, Writing – review & editing. Vicky H.Y. Wong: Methodology, Investigation, Formal analysis, Supervision, Writing – review & editing. Ariel M. Zeleznikow-Johnston: Methodology, Software, Formal analysis, Writing – original draft, Writing – review &

References (71)

  • C.R. Hooijmans et al.

    DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice

    Neurobiol. Dis

    (2009)
  • C. Janus et al.

    Impaired conditioned taste aversion learning in APP transgenic mice

    Neurobiol. Aging

    (2004)
  • D.L. King et al.

    Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav

    Brain Res

    (1999)
  • M. Koronyo-Hamaoui et al.

    Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model

    NeuroImage

    (2011)
  • J.M. Lassalle et al.

    Effects of the genetic background on cognitive performances of TG2576 mice

    Behav. Brain Res

    (2008)
  • E. Levy-Gigi et al.

    Impaired context reversal learning, but not cue reversal learning, in patients with amnestic mild cognitive impairment

    Neuropsychologia

    (2011)
  • A. Masuda et al.

    Cognitive deficits in single App knock-in mouse models

    Neurobiol. Learn. Mem

    (2016)
  • P.R. Mouton et al.

    Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice

    Neurosci. Lett

    (2009)
  • M. Musilli et al.

    Behavioral effects of Rho GTPase modulation in a model of Alzheimer's disease. Behav

    Brain Res

    (2013)
  • F.M. Nadal-Nicolás et al.

    The aging rat retina: from function to anatomy

    Neurobiol. Aging

    (2018)
  • M.-C. Pardon et al.

    Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels

    Neurobiol. Aging

    (2009)
  • N.V. Patel et al.

    Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models

    Neurobiol. Aging

    (2005)
  • T.O. Piiponniemi et al.

    Acquisition and reversal of visual discrimination learning in APPSwDI/Nos2−/− (CVN) mice

    Neurosci. Lett

    (2017)
  • S. Rabe-Hesketh et al.

    Maximum likelihood estimation of limited and discrete dependent variable models with nested random effects

    J. Econom

    (2005)
  • C. Romberg et al.

    A touch screen-automated cognitive test battery reveals impaired attention, memory abnormalities, and increased response inhibition in the TgCRND8 mouse model of Alzheimer's disease

    Neurobiol. Aging

    (2013)
  • A. Savonenko et al.

    Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to β-amyloid deposition and neurotransmitter abnormalities

    Neurobiol. Dis

    (2005)
  • M.J. Schafer et al.

    Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice

    Neurobiol. Aging

    (2015)
  • K.R. Stover et al.

    Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Behav

    Brain Res

    (2012)
  • K.R. Stover et al.

    Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease. Behav

    Brain Res

    (2015)
  • A. Zeleznikow-Johnston et al.

    Environmental enrichment enhances cognitive flexibility in C57BL/6 mice on a touchscreen reversal learning task

    Neuropharmacology

    (2017)
  • D. Zhao et al.

    Characterization of the circumlimbal suture model of chronic iop elevation in mice and assessment of changes in gene expression of stretch sensitive channels

    Front. Neurosci

    (2017)
  • M.S. Albert et al.

    Preclinical prediction of AD using neuropsychological tests

    J. Int. Neuropsychol. Soc

    (2001)
  • Alzheimer's Disease International, 2015. World Alzheimer Report 2015: The global impact of dementia [WWW Document]....
  • D. Andriuta et al.

    Differentiating between Alzheimer's disease and vascular cognitive impairment: is the “memory versus executive function” contrast still relevant?

    J. Alzheimer's. Dis

    (2018)
  • K. Baruch et al.

    Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology

    Nat. Commun

    (2015)
  • View full text